For: | Smith C, Zheng W, Dong J, Wang Y, Lai J, Liu X, Yin F. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World J Gastroenterol 2022; 28(27): 3297-3313 [PMID: 36158269 DOI: 10.3748/wjg.v28.i27.3297] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i27/3297.htm |
Number | Citing Articles |
1 |
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(21): 15500 doi: 10.3390/ijms242115500
|
2 |
Antonella Argentiero, Alessandro Andriano, Ingrid Catalina Caradonna, Giulia de Martino, Vanessa Desantis. Decoding the Intricate Landscape of Pancreatic Cancer: Insights into Tumor Biology, Microenvironment, and Therapeutic Interventions. Cancers 2024; 16(13): 2438 doi: 10.3390/cancers16132438
|
3 |
Xiaofei Cheng, Wenguang He, Weixiang Zhong, Congke Tong, Guosheng Wu. Immunotherapy as a promising treatment strategy for dmmr colorectal cancer with brain metastasis: a case report. Journal of Cancer Metastasis and Treatment 2023; doi: 10.20517/2394-4722.2023.85
|
4 |
Lingyun Feng, Lijuan Guo, Yoshimasa Tanaka, Li Su. Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance. International Journal of Molecular Sciences 2022; 23(23): 15236 doi: 10.3390/ijms232315236
|
5 |
Diego J. Jiménez, Aadil Javed, Teresa Rubio-Tomás, Ndioba Seye-Loum, Carles Barceló. Clinical and Preclinical Targeting of Oncogenic Pathways in PDAC: Targeted Therapeutic Approaches for the Deadliest Cancer. International Journal of Molecular Sciences 2024; 25(5): 2860 doi: 10.3390/ijms25052860
|
6 |
Kadir Çorbacı, Meryem Gunay Gurleyik, Aylin Gonultas, Fugen Aker, Mehmet Onur Gul, Metin Tilki. Evaluation of prognostic significance of histopathological characteristics and tumor-infiltrating lymphocytes for pancreatic cancer survival. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-79342-x
|
7 |
Mengyang Ding, Jingyu Liu, Honghui Lv, Yanlin Zhu, Yumiao Chen, Hui Peng, Sairong Fan, Xiaoming Chen. Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1097772
|
8 |
Wisdom O. Maduabuchi, Felista L. Tansi, Bernd Faenger, Paul Southern, Quentin A. Pankhurst, Frank Steiniger, Martin Westermann, Ingrid Hilger. Local Magnetic Hyperthermia and Systemic Gemcitabine/Paclitaxel Chemotherapy Triggers Neo-Angiogenesis in Orthotopic Pancreatic Tumors without Involvement of Auto/Paracrine Tumor Cell VEGF Signaling and Hypoxia. Cancers 2023; 16(1): 33 doi: 10.3390/cancers16010033
|
9 |
Jee-Hyung Lee, Sang-Hyub Lee, Sang-Kook Lee, Jin-Ho Choi, Seohyun Lim, Min-Song Kim, Kyung-Min Lee, Min-Woo Lee, Ja-Lok Ku, Dae-Hyun Kim, In-Rae Cho, Woo-Hyun Paik, Ji-Kon Ryu, Yong-Tae Kim. Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells. Cancers 2023; 15(9): 2642 doi: 10.3390/cancers15092642
|
10 |
Ann Mary Joseph, Ahmad Al Aiyan, Basel Al-Ramadi, Shiv K. Singh, Uday Kishore. Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1323198
|